Impact of the recommendations for the redefinition of myocardial infarction on diagnosis and prognosis in an unselected United Kingdom cohort with suspected cardiac chest pain

American Journal of Cardiology

Volumn 93, Issue 7, 2004, Pages 817-821

  Trevelyan, Jasper ^a   Needham, Edward W A ^b   Smith, Stephen C H ^b   Mattu, Raj K ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; THORAX PAIN; UNITED KINGDOM; UNSTABLE ANGINA PECTORIS; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; COHORT STUDIES; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; GREAT BRITAIN; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; PROGNOSIS; SINGLE-BLIND METHOD; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 1842529853     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.12.016     Document Type: Article

References (17)

1. Joint European Society of Cardiology/American College of Cardiology. Committee Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 36:2000;959-969.
2. Koukkunen H., Penttila K., Kemppainen A., Penttila I., Halinen M., Rantanen T., Pyorala K. Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria. Am J Cardiol. 88:2001;727-731.
3. Data on file at Roche Diagnostics Ltd
4. Collinson P.O., Rosalki S.B., Kuwana T., Garratt H.M., Ramhamadamy E.M., Baird I.M., Greenwood T.W. Early diagnosis of acute myocardial infarction by CK-MB mass measurements. Ann Clin Biochem. 29:1992;43-47.
5. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.-M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Circulation. 90:1994;583-612.
6. Hamm C.W., Ravkilde J., Gerhardt W., Jorgensen P., Peheim E., Ljungdahl L., Goldman B., Katus H.A. The prognostic value of serum troponin T in unstable angina (see comments). N Engl J Med. 327:1992;146-150.
7. Hamm C.W., Goldmann B.U., Heeschen C., Kreymann G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I (see comments). N Engl J Med. 337:1997;1648-1653.
8. Ravkilde J.L., Horder M., Gerhardt W., Ljungdahl L., Pettersson T., Tryding N., Moller B.H., Hamfelt A., Graven T., Asberg A. Troponin T in acute myocardial infarction. Diagnosis and prognosis in patients admitted for suspected acute myocardial infarction. Ugeskr Laeg. 156:1994;7206-7211.
9. Ravkilde J., Nissen H., Horder M., Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol. 25:1995;574-581.
10. Richards A., Lainchbury J., Nicholls M. Unsatisfactory redefinition of myocardial infarction. Lancet. 357:2001;1635-1636.
11. Brush J.J., Brand D., Acampora D., Chalmer B., Wackers F. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med. 312:1985;1137-1141.
12. Rude R., Poole K., Muller J., Turi Z., Rutherford J., Parker C., Roberts R., Raabe D.S. Jr, Gold H.K., Stone P.H. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3, 697 patients. Am J Cardiol. 52:1983;936-942.
13. Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group (see comments). Circulation. 93:1996;1651-1657.
14. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B., Katus H.A., Hamm C.W., O'Hanesian M.A., Wagner G.S., Kleiman N.S., Harrell F.E. Jr, Califf R.M., Topol E.J. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators (see comments). N Engl J Med. 335:1996;1333-1341.
15. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., Fischer G.A., Fung A.Y., Thompson C., Wybenga D., Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes (see comments). N Engl J Med. 335:1996;1342-1349.
16. for The FRISC II Investigators, Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease the FRISC II invasive randomised trial. Lancet. 356:2000;9-16.
17. for The TACTICS-TIMI 18 Investigators, Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis A., Neumann F.-J., Robertson D.H., Delucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E. Comparison of early invasive and conversative strategies in patients with unstable coronary syndromes treated with the glycoprotein protein IIa/IIIb inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.